EPO and neoplasm: The lymph node as a new target of EPO was presented by Lee et al. (121) They showed that EPO can stimulate both lymph node lymphangiogenesis and nodal metastasis by increased migration, capillary-like tube formation, and dose- and time-dependent proliferation of human lymphatic endothelial cells in tumor-bearing animals.